Facebook
Instagram
Linkedin
Pinterest
Reddit
X
Youtube
Sign in
Home
Safe Snack Guides
Introduction
Peanut and Tree Nut Free Guide
Milk (Dairy) Free Guide
Gluten Free Guide
Sesame Free Guide
Custom Guide
Allergence
Coupons and Offers
Resources
Newsletter Archive
Frequently Asked Questions (FAQ)
SnackSafely.com Manufacturer Partnership
About
Media Kit
Advertising Guide
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guides
Introduction
Peanut and Tree Nut Free Guide
Milk (Dairy) Free Guide
Gluten Free Guide
Sesame Free Guide
Custom Guide
Allergence
Coupons and Offers
Resources
Newsletter Archive
Frequently Asked Questions (FAQ)
SnackSafely.com Manufacturer Partnership
About
Media Kit
Advertising Guide
Contact Us
Search
Home
Tags
Dupixent
Tag: Dupixent
Study Finds Eczema Drug Dupilumab Drives Down Food Allergy IgE but...
Dave Bloom
-
2026/09/30
0
Dupilumab Lowered IgE Levels in Small Study
Dave Bloom
-
2025/03/17
0
Dupixent® Phase 3 Trial Shows Positive Results in Children Ages 1-11...
News Wire ~ 3rd Party Press Release
-
2022/07/15
0
FDA Approves First Treatment for Eosinophilic Esophagitis (EoE), a Chronic Immune...
News Wire ~ 3rd Party Press Release
-
2022/05/23
0
Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and...
News Wire ~ 3rd Party Press Release
-
2020/10/26
0
FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...
News Wire ~ 3rd Party Press Release
-
2020/05/28
0
FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents
News Wire ~ 3rd Party Press Release
-
2019/03/12
0
Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...
News Wire ~ 3rd Party Press Release
-
2018/10/15
0
Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...
Dave Bloom
-
2018/09/27
1
Study: Dupilumab Showed Positive Phase 3 Results in Adolescents with Inadequately...
News Wire ~ 3rd Party Press Release
-
2018/05/17
0
1
2
Page 1 of 2